Related Experiment Videos
Prospects for gene therapy in pediatric neurosurgery
M G Kaplitt1, B Darakchiev, M J During
1Department of Surgery, New York Hospital-Cornell University Medical College, New York 10021, USA. kaplitm@rockvax.rockefeller.edu
Pediatric Neurosurgery
|August 7, 1998
Summary
Gene therapy offers promising treatments for pediatric neurological diseases using viral vectors. Advances in gene delivery systems and genetic information will expand its role in pediatric neurosurgery.
Area of Science:
- Neuroscience
- Genetics
- Pediatric Medicine
Background:
- Gene therapy is a key tool for studying and treating pediatric neurological disorders.
- Viral vectors are commonly used for gene delivery to the central nervous system.
- Retroviruses are limited to dividing cells, while DNA-based viruses can target neurons.
Purpose of the Study:
- To review gene therapy strategies for pediatric neurological diseases.
- To discuss the advantages and limitations of different viral vectors.
- To highlight the potential of gene therapy in treating inherited defects and brain tumors in children.
Main Methods:
- Review of current gene therapy approaches for pediatric neurological conditions.
- Analysis of various viral vector systems (adenovirus, AAV, HSV) for gene delivery.
- Evaluation of preclinical studies and ongoing clinical trials.
Main Results:
- Preclinical studies show promise for gene therapy in pediatric CNS disease models.
- Several trials are underway for pediatric brain tumors.
- A protocol for an inherited neurological defect has been approved for clinical trials.
Conclusions:
- Gene therapy holds significant potential for pediatric neurosurgery.
- Vector choice depends on factors like toxicity, gene size, and viral titer.
- Ongoing research and genetic advancements will drive future applications.